New imaging technique may help in early detection of prostate cancer

August 29, 2017

Similar findings were described by Daniela Bokor of Bracco Diagnostics, who reported on a separate study sponsored by the company at medical centers in Europe.

In CEUS imaging, patients undergoing ultrasound scans receive an arm vein injection of a special contrast agent that does not contain dye and does not require ionizing radiation. CEUS imaging is FDA-approved in the United States for certain types of cardiac imaging but is approved in Europe, Canada, Asia and South America for pinpointing disease and tumors in other parts of the body as well.

"CEUS can offer a safe and cost effective means of improving the accuracy of ultrasound diagnoses," according to Dr. Steven Feinstein, Director of Echocardiography at Rush University Medical Center in Chicago, director of the conference, and co-president of the International Contrast Ultrasound Society.

Source: International Contrast Ultrasound Society